NMPA Approval

Potassium Sodium Dehydroandrographolide Succinate for Injection

Approval Number

国药准字H20046406

Company广东宏远集团药业有限公司

Registration Date

April 1, 2020

Drug Information

Generic Name

注射用炎琥宁

Dosage Form

注射剂

Strength

40mg

Drug Type

化学药品

Registration Date

April 1, 2020

Company Information

Applicant Company

Company Name广东宏远集团药业有限公司

Manufacturing Company

Company Name广东宏远集团药业有限公司

Company Address

东莞市东城樟村工业区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用炎琥宁 - NMPA 批准文号 | MedPath